ResearcherThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteNo recent work listed

Adriana Estrada‐Bernal

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0555-2766; OpenAlex author ID A5022348436. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2015: 1 paper

Papers 1

MEK inhibitor GSK1120212-mediated radiosensitization of pancreatic cancer cells involves inhibition of DNA double-strand break repair pathways. Co-author DOI 10.1080/15384101.2015.1104437 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Meredith Ann Morgan · 1 shared paper, 2015 · strength 0.05
- Paper MEK inhibitor GSK1120212-mediated radiosensitization of pancreatic cancer cells involves inhibition of DNA double-stran… DOI 10.1080/15384101.2015.1104437 ↗
Moumita Chatterjee · 1 shared paper, 2015 · strength 0.05
- Paper MEK inhibitor GSK1120212-mediated radiosensitization of pancreatic cancer cells involves inhibition of DNA double-stran… DOI 10.1080/15384101.2015.1104437 ↗
Terence Marques Williams · 1 shared paper, 2015 · strength 0.05
- Paper MEK inhibitor GSK1120212-mediated radiosensitization of pancreatic cancer cells involves inhibition of DNA double-stran… DOI 10.1080/15384101.2015.1104437 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.